Britain Seeks Strategic Research Funds

LONDON—Strategic research in Britain should be funded by a new route that is independent of the support given to academic science through the University Grants Committee and research councils and the customer-contractor relationship used by government departments for applied research. This view is contained in a new report on civilian R&D from the House of Lords Select Committee on Science and Technology, a body of ten peers with considerable experience in science and engineering. The repo

| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

This view is contained in a new report on civilian R&D from the House of Lords Select Committee on Science and Technology, a body of ten peers with considerable experience in science and engineering. The report, published January 8, defines strategic research as that "undertaken with eventual practical applications in mind even though these cannot be clearly specified."

Strategic research with commercial objectives may differ markedly from strategic research with scientific, social or environmental objectives, they argue. So they advocate a new approach "to promote that strategic research which is of most significance to the United Kingdom's economic future." They believe some of the cash should come from the present budgets of the research councils and government departments, but that the central government should invest new funds that would lead to investment by private industry.

The 39 recommendations in the report include a strong plea for mandatory disclosure by British ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies